Subject of the day
MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
FY 2016–2025 · 10 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $1.89B | +18.1% | |
| Operating income | $446.87M | +48.6% | |
| Net income | $451.12M | +61.9% | |
| Cash from ops | $433.37M | +15.7% |
$581.95
▼ -15.03 (-2.5%)
| 52w hi | $620.59 |
|---|---|
| 52w lo | $393.42 |
| Vol | 150.36K |
| As of | Aug 13 |
Our score +0.15
| Short | -0.11 |
|---|---|
| Medium | +0.26 |
| Long | +0.44 |
computed 2026-08-13
Medpace Holdings, Inc.
Healthcare · Diagnostics & Research
| Market cap | $16.24B |
|---|---|
| Enterprise value | $16.30B |
| Trailing P/E | 34.21x |
| Forward P/E | 30.14x |
| EV / EBITDA | 26.68x |
| P / S (ttm) | 5.84x |
| Profit margin | 17.7% |
| Return on equity | 162.2% |
| Revenue growth | +17.2% |
| Earnings growth | +37.1% |
| Debt / equity | 33.22 |
| Beta vs SPX | 1.02 |
|---|---|
| Corr SPX | 0.29 |
| Annual vol | 57.4% |
| Annual ret | +36.6% |
| Sharpe | 0.64 |
| Max DD | -36.6% |
Window: 504 trading days (504 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.30 | |
| Sector | +0.12 | |
| Technical | +0.00 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $600.40 | $602.50 | $581.29 | $581.95 | 150.36K |
| Aug 12 | $598.20 | $604.89 | $593.14 | $596.98 | 310.40K |
| Aug 11 | $604.32 | $608.18 | $598.22 | — | 158.36K |
| Aug 10 | $588.99 | $603.34 | $588.99 | $602.43 | 233.60K |
| Aug 7 | $590.45 | $594.99 | $582.08 | $590.67 | 136.50K |